Conti et al. proposed that the activation of TLR2 during COVID-19 infection could result in the production of proinflammatory cytokines like IL-1, and its interaction with the virus particles causes immunopathological consequences that lead to death in COVID-19 patients [35]. The gene discussed is TLR2; the disease is COVID-19.